Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing

Genes, Chromosomes & Cancer
Yeonjoo JungJaesang Kim

Abstract

An increasing number of chromosomal aberrations is being identified in solid tumors providing novel biomarkers for various types of cancer and new insights into the mechanisms of carcinogenesis. We applied next generation sequencing technique to analyze the transcriptome of the non-small cell lung carcinoma (NSCLC) cell line H2228 and discovered a fusion transcript composed of multiple exons of ALK (anaplastic lymphoma receptor tyrosine kinase) and PTPN3 (protein tyrosine phosphatase, nonreceptor Type 3). Detailed analysis of the genomic structure revealed that a portion of genomic region encompassing Exons 10 and 11 of ALK has been translocated into the intronic region between Exons 2 and 3 of PTPN3. The key net result appears to be the null mutation of one allele of PTPN3, a gene with tumor suppressor activity. Consistently, ectopic expression of PTPN3 in NSCLC cell lines led to inhibition of colony formation. Our study confirms the utility of next generation sequencing as a tool for the discovery of somatic mutations and has led to the identification of a novel mutation in NSCLC that may be of diagnostic, prognostic, and therapeutic importance.

References

May 29, 2000·Trends in Genetics : TIG·P RiceA Bleasby
Apr 5, 2002·Genome Research·W James Kent
May 25, 2004·Science·Zhenghe WangVictor E Velculescu
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jussi P KoivunenPasi A Jänne
Jan 13, 2009·Nature·Christopher A MaherArul M Chinnaiyan
Feb 24, 2009·Current Opinion in Genetics & Development·John R Prensner, Arul M Chinnaiyan
May 2, 2009·Biochimica Et Biophysica Acta·J Chad Brenner, Arul M Chinnaiyan
Dec 17, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Benjamin SolomonD Ross Camidge
Nov 26, 2010·The Mount Sinai Journal of Medicine, New York·Jaya SangodkarGoutham Narla

❮ Previous
Next ❯

Citations

May 2, 2012·BMC Bioinformatics·Layla OesperBenjamin J Raphael
Feb 5, 2014·Future Oncology·Adam GorczyńskiWojciech Biernat
Aug 29, 2013·Future Oncology·Kehua WuWilliam Chi Cho
Jun 13, 2013·Biochimica Et Biophysica Acta·Caroline E Nunes-XavierRafael Pulido
Feb 2, 2016·Nature Biotechnology·Grace X Y ZhengHanlee P Ji
Sep 25, 2012·Expert Opinion on Therapeutic Targets·Anna KruczynskiLaurence Lamant
Feb 15, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lynette M ShollJason L Hornick
Feb 6, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Douglas D FangChi-Chung Chan
Feb 13, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Mineui HongYoon-La Choi
Dec 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tianhong LiDavid R Gandara
Jun 25, 2013·Clinical Lung Cancer·Sacha I Rothschild, Oliver Gautschi
Jun 19, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Solange PetersRolf Stahel
Dec 4, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Nov 21, 2012·Tuberculosis and Respiratory Diseases·Ji Woong Son
Jan 30, 2015·Biology of the Cell·Monika A Davare, Cristina E Tognon
Apr 19, 2015·Journal of Hematology & Oncology·Chaitanya IragavarapuDelong Liu
Jan 15, 2014·The Journal of Molecular Diagnostics : JMD·Maruja E LiraMao Mao
Aug 31, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Hallberg, R H Palmer
Mar 1, 2018·Thoracic Cancer·Xue DuHong-Jun Gao
Jan 13, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jason N RosenbaumEric J Duncavage
Dec 28, 2017·Journal of Clinical and Experimental Hematopathology : JCEH·Naoko TsuyamaKengo Takeuchi
Feb 26, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ganesh UmapathyRuth H Palmer
Sep 26, 2013·Nature Reviews. Cancer·Bengt Hallberg, Ruth H Palmer
Oct 5, 2013·Clinical Pharmacology and Therapeutics·B SolomonA T Shaw
May 17, 2019·The American Journal of Surgical Pathology·Florian HallerAbbas Agaimy
Nov 24, 2018·BMC Cancer·Claudia VollbrechtMaximilian von Laffert
Aug 2, 2019·Cancers·Stephen P DucrayGerda Egger
Nov 9, 2017·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·Ayako SuzukiYutaka Suzuki
Apr 4, 2019·Frontiers in Physiology·Kengo Takeuchi
Apr 15, 2020·Cancers·Abdulaziz B Hamid, Ruben C Petreaca
Jan 27, 2017·Cancer Discovery·Jessica J LinAlice T Shaw
Dec 4, 2013·Molecular Cancer Research : MCR·Dara L AisnerMarileila Varella-Garcia
Mar 12, 2019·Current Medicinal Chemistry·Sitanshu S SinghSeetharama D Jois

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.